Nitto Denko Avecia Revenue, Growth & Competitor Profile

DBA OLIGO MEDICINE

Company Profile & Annual Report for Nitto Denko Avecia

Access the complete profile.

Nitto Denko Avecia Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325 Chemical Manufacturing 325411 Medicinal & Botanical Manufacturing
Address	125 Fortune Boulevard Milford, MA 01757

Note: Revenues for privately held companies are statistical evaluations.


Nitto Denko Avecia's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nitto Denko Avecia's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Nitto Denko Avecia is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Nitto Denko Avecia Annual Revenue and Growth Rate

Nitto Denko Avecia	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nitto Denko Avecia's revenues are gauged from an analysis of company filings.

Nitto Denko Avecia's Income Statement (based on Industry Averages)

Nitto Denko Avecia P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Nitto Denko Avecia is developing and marketing. Nitto Denko Avecia doesn't have any recent trademark applications, indicating Nitto Denko Avecia is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AVECIA Manufacturing, namely, contract manufacturing in the field of oligonucleotides	03/16/2012
OLIGO FASTER SMARTER BETTER biochemical contract manufacturing services	05/27/2011
OLIGOMEDICINES Manufacturing, namely, contract manufacturing in the field of oligonucleotides; development services, namely, design and development of manufacturing processes for others in the field of oligonucleotides	09/15/2010

See all trademarks and details in the Full Report.

Market Share of Nitto Denko Avecia's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nitto Denko Avecia, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Nitto Denko Avecia. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BOSTON SCIENTIFIC	Marlborough, MA	100
INSULET	Acton, MA	16
INSTRUMENTATION LABORATORY	Bedford, MA	14
NITTO DENKO AVECIA	Milford, MA	2
CANDELA	Marlborough, MA	2
ANIKA THERAPEUTICS	Bedford, MA	2

Future Competition: Nitto Denko Avecia's Fastest Growing Competitors

These companies are in the same general field as Nitto Denko Avecia and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)